摘要
基质金属蛋白酶(matrix metalloproteinases,MMPs)是一组锌离子依赖性的内源性蛋白水解酶,其主要功能是降解细胞外基质;基质金属蛋白酶抑制因子是其内源性抑制因子,二者协同以维持细胞外基质的动态平衡.近年研究发现,基质金属蛋白酶对原发性开角型青光眼的发生和发展起重要作用.文中就基质金属蛋白酶在原发性开角型青光眼中的表达及作用进行综述.
出处
《中国实用眼科杂志》
CSCD
北大核心
2014年第7期813-816,共4页
Chinese Journal of Practical Ophthalmology
参考文献26
-
1Lutjen-Drecoll E. Functional morphology of the trabecular mesh- work in primate eyes[J]. Prog Ret Eye Res, 1999, 18(1): 91-119.
-
2Wax MB,Tezel G,Edward PD. Clinical and ocular histopatholog- ical findings in a patient with normal-pressure glaucoma[J]. Arch Ophthalmol, 1998,116(8) :933-1001.
-
3Steppo Rnkk,Petri Rekonen,Kai Kaarniranta,et al. Matrix metal- loproteinases and their inhibitors in the chamber angle of nor- mal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma[J]. Graefe's Arch Clin Exp Ophthalmol, 2007,245 (5) : 697-704.
-
4Agapova OA, Ricard CS, Salvador-Silva M, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloprotein- ases in human optic nerve head astrocytes[J]. Glia, 2001,33 (3) :205-216.
-
5Nagase H,Woessner JF Jr. Matrix metalloproteinases[J]. J Biol Chem, 1999,274(31 ) :21491-21494.
-
6Visse R,Nagase H. Matrix metalloproteinases and tissue inhibi- tors of metalloproteinases: structure, function, and biochemistry [J]. Circ Res,2003,92(8):827-839.
-
7Kerrigan JJ,Mansell JP,Sandy JR. Matrix turnover [ J].J Orthod, 2000,27(3) :227-233.
-
8Alexander JP, Samples JR, Van Buskirk EM, et al. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork[J]. Invest Ophthalmol Vis Sci, 1991,32( 1 ) : 172-180.
-
9Agapova, Kaufman PL, Lucarelli M J, et al. Differential expres- sion of matrix metalloproteinases in monkey eyes with experi- mental glaucoma or optic nerve transection [J]. Brain Res, 2003,967(1-2) : 132-143.
-
10Sivak JM,Fini ME. MMPs in the eye:emerging roles for matrix metalloproteinases in ocular physiology[J]. Prog Retin Eye Res, 2002,21(1 ) : 1-14.
同被引文献19
-
1张佳莹,冷非,彭绍民.抗青光眼眼表药物与人结膜成纤维细胞TGF-β、MMP的表达[J].国际眼科杂志,2007,7(5):1294-1297. 被引量:7
-
2Adlina AR,Alisa-Victoria K, Shatriah I, et al. Optic disc lopog raphy in Malay patients with normaLtension glaucoma and pri mary open-angle glaucoma[J]. Clin Ophthalmol, 2014, 12 (8) 2533-2539.
-
3Nesher R,Israel Glaucoma Screening Group. Prevalence of in- creased intraocular pressure and optic disk cupping: muhicenter glaucoma screening in Israel during the 2009 and 2010 World Glaucoma Weeks[J]. Isr Med Assoc J, 2014,16(8) :483-486.
-
4Nga AD, Yap SL, Samsudin A, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of pa- tients with primary angle closure glaucoma: a quantitative study [J]. BMC Ophthalmol,2014,24(14) :33.
-
5Kara S, Yildirim N, Ozer A,et al. Matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and transforminggrow th factor beta 1 in the aqueous humor and serum of patients w ithp- seudoexfoliation syndrome [ J ]. Clin Ophthalmol, 2014, 8: 305- 309.
-
6Fountoulakis N, Labiris G, Aristeidou A, et al. Tissue inhibitor of metalloproteinase 4 in aqueous humor of patients with primary open angle glaucoma, pseudoexfoliation syndrome and pseudoexfo]iative glaucoma and its role in proteolysis imbalance [ J ]. BMC Ophthal- mol,2013,8 ( 13 ) :69.
-
7De Groef L, Van Hove I, Dekeyster E, et al. MMPs in the neuroreti- na and optic nerve: modulators of glaucoma pathogenesis and re- pair [ J ]. Invest Ophthalmol Vis Sci, 2014,55 ( 3 ) : 1953-1964.
-
8De Groef L, Van Hove I, Dekeyster E,et al. MMPs in the trabecu- lar meshwork : promising targets for future glaucoma therapies[ J]. Invest Ophthalmol Vis Sci,2013,54(12) :7756-7763.
-
9Kim B, Abdel-Rahman MH, Wang T, et al. Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimen- tal retinal detachment [ J ]. Invest Ophthalmol Vis Sci, 2014,55 (4) :2031-2040.
-
10王翠青,申家泉.开角型青光眼患者房水中MMP-3、TIMP-1的表达及意义[J].山东医药,2008,48(47):22-23. 被引量:1
二级引证文献4
-
1黄万碧,何高均,任玉平.综合护理干预对青光眼患者自我管理行为及视功能的影响[J].实用临床医药杂志,2016,20(12):139-141. 被引量:29
-
2王圣识,庄博,孙铁权,龙梅欢.毛果芸香碱联合拉坦前列素治疗原发性急性闭角型青光眼的临床研究[J].中国现代药物应用,2016,10(16):123-124. 被引量:4
-
3李方芳.血清及脑脊液MMP及TIMP指标在病毒性脑炎患儿中的检测价值研究[J].临床研究,2017,25(1):167-168. 被引量:2
-
4张丽,孙文静.和血明目片联合玻璃酸钠滴眼液对老年性白内障伴青光眼患者视功能及房水sCD44、TIMP-2水平的影响[J].临床医学研究与实践,2020,5(36):160-162. 被引量:2
-
1刘琳琳,曾祥云.基质金属蛋白酶及其抑制剂与原发性开角型青光眼[J].赣南医学院学报,2012,32(4):642-644. 被引量:2
-
2戴南平,姚克,徐蔚,荣翱,朱茜,牛耘丽.兔眼人工晶体植入术后TIMPs在晶体上皮细胞的表达及其意义[J].同济大学学报(医学版),2004,25(6):469-472. 被引量:1
-
3戴南平,姚克.兔眼IOL术后基质金属蛋白酶抑制因子在虹膜、晶状体上皮细胞的表达[J].眼科研究,2004,22(3):251-255. 被引量:4
-
4朱丹,黎晓新.基质金属蛋白酶与增生性玻璃体视网膜病变[J].内蒙古医学院学报,2006,28(2):139-144.
-
5殷岩,杨佩菲,李青.基质金属蛋白酶及其抑制剂与白内障关系的研究进展[J].福建医药杂志,2005,27(5):164-166.
-
6濮清岚,吴瑜瑜.基质金属蛋白酶与原发性开角型青光眼关系的研究进展[J].临床眼科杂志,2005,13(1):91-94.
-
7栗映梅,申家泉.基质金属蛋白酶及其组织抑制因子在人眼葡萄膜中的表达及分布[J].眼科研究,2009,27(2):98-99. 被引量:1
-
8毛文书,曾凌华,马巧云,陈又昭,戴祖优,唐佩青,郭向明,李丹扬,苏文.直流电锌离子导入治疗视网膜色素变性的初步报告[J].眼科学报,1990,6(3):88-90.
-
9王静波,惠延年.基质金属蛋白酶及其抑制剂与眼部疾病[J].眼科新进展,2005,25(1):79-82. 被引量:1
-
10尹丽,张德秀.基质金属蛋白酶与原发性开角型青光眼[J].国外医学(眼科学分册),2004,28(3):198-201. 被引量:3